These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 10332072)

  • 41. High drug load, stable, manufacturable and bioavailable fenofibrate formulations in mesoporous silica: a comparison of spray drying versus solvent impregnation methods.
    Hong S; Shen S; Tan DC; Ng WK; Liu X; Chia LS; Irwan AW; Tan R; Nowak SA; Marsh K; Gokhale R
    Drug Deliv; 2016; 23(1):316-27. PubMed ID: 24853963
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Enhanced oral bioavailability of fenofibrate using polymeric nanoparticulated systems: physicochemical characterization and in vivo investigation.
    Yousaf AM; Kim DW; Oh YK; Yong CS; Kim JO; Choi HG
    Int J Nanomedicine; 2015; 10():1819-30. PubMed ID: 25784807
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combining in vitro and in silico methods for better prediction of surfactant effects on the absorption of poorly water soluble drugs-a fenofibrate case example.
    Berthelsen R; Sjögren E; Jacobsen J; Kristensen J; Holm R; Abrahamsson B; Müllertz A
    Int J Pharm; 2014 Oct; 473(1-2):356-65. PubMed ID: 24997410
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Enhancement of oral bioavailability of fenofibrate by solid self-microemulsifying drug delivery systems.
    Kim GG; Poudel BK; Marasini N; Lee DW; Hiep TT; Yang KY; Kim JO; Yong CS; Choi HG
    Drug Dev Ind Pharm; 2013 Sep; 39(9):1431-8. PubMed ID: 23046292
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Alternative solvent-free preparation methods for felodipine surface solid dispersions.
    Kerc J; Srcic S; Kofler B
    Drug Dev Ind Pharm; 1998 Apr; 24(4):359-63. PubMed ID: 9876596
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Deciphering nifedipine in vivo delivery from modified release dosage forms: Identification of food effect.
    Ilić M; Kovačević I; Parojčić J
    Acta Pharm; 2015 Dec; 65(4):427-41. PubMed ID: 26677899
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In Vivo Performance of Fenofibrate Formulated With Ordered Mesoporous Silica Versus 2-Marketed Formulations: A Comparative Bioavailability Study in Beagle Dogs.
    Bukara K; Schueller L; Rosier J; Daems T; Verheyden L; Eelen S; Martens JA; Van den Mooter G; Bugarski B; Kiekens F
    J Pharm Sci; 2016 Aug; 105(8):2381-5. PubMed ID: 27364460
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Formulation, evaluation and optimization of the felodipine nanosuspension to be used for direct compression to tablet for in vitro dissolution enhancement.
    Mori D; Makwana J; Parmar R; Patel K; Chavda J
    Pak J Pharm Sci; 2016 Nov; 29(6):1927-1936. PubMed ID: 28375107
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The influence of supercritical carbon dioxide (SC-CO2) processing conditions on drug loading and physicochemical properties.
    Ahern RJ; Crean AM; Ryan KB
    Int J Pharm; 2012 Dec; 439(1-2):92-9. PubMed ID: 23041132
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dissolution and absorption modeling: model expansion to simulate the effects of precipitation, water absorption, longitudinally changing intestinal permeability, and controlled release on drug absorption.
    Johnson KC
    Drug Dev Ind Pharm; 2003 Sep; 29(8):833-42. PubMed ID: 14570304
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of Polymer/Surfactant as Carriers on the Solubility and Dissolution of Fenofibrate Solid Dispersion.
    Yang B; Wu L; Ke J; Zhou L; Chen M; Li S; Feng X
    AAPS PharmSciTech; 2019 Feb; 20(3):102. PubMed ID: 30723877
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Formulation of fenofibrate liquisolid tablets using central composite design.
    Patel T; Patel LD; Suhagia BN; Soni T; Patel T
    Curr Drug Deliv; 2014; 11(1):11-23. PubMed ID: 24712439
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impregnation of mesoporous silica with poor aqueous soluble molecule using pressurized carbon dioxide: Is the solubility in the supercritical and subcritical phase a critical parameter?
    Koch N; Jennotte O; Grignard B; Lechanteur A; Evrard B
    Eur J Pharm Sci; 2020 Jul; 150():105332. PubMed ID: 32361178
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Investigation of the Intra- and Interlaboratory Reproducibility of a Small Scale Standardized Supersaturation and Precipitation Method.
    Plum J; Madsen CM; Teleki A; Bevernage J; da Costa Mathews C; Karlsson EM; Carlert S; Holm R; Müller T; Matthews W; Sayers A; Ojala K; Tsinsman K; Lingamaneni R; Bergström CA; Rades T; Müllertz A
    Mol Pharm; 2017 Dec; 14(12):4161-4169. PubMed ID: 29043811
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of fillers on dissolution kinetic of fenofibrate dry foams.
    Lenz E; Sprunk A; Kleinebudde P; Page S
    Pharm Dev Technol; 2015; 20(5):570-8. PubMed ID: 24901031
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hydrodynamic Effects on Drug Dissolution and Deaggregation in the Small Intestine-A Study with Felodipine as a Model Drug.
    Lindfors L; Jonsson M; Weibull E; Brasseur JG; Abrahamsson B
    J Pharm Sci; 2015 Sep; 104(9):2969-76. PubMed ID: 25980801
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of oil phase composition on the skin permeation of felodipine from o/w microemulsions.
    Trotta M; Morel S; Gasco MR
    Pharmazie; 1997 Jan; 52(1):50-3. PubMed ID: 9035235
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A comparison of the physical stability of amorphous felodipine and nifedipine systems.
    Marsac PJ; Konno H; Taylor LS
    Pharm Res; 2006 Oct; 23(10):2306-16. PubMed ID: 16927182
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Particle design of poorly water-soluble drug substances using supercritical fluid technologies.
    Yasuji T; Takeuchi H; Kawashima Y
    Adv Drug Deliv Rev; 2008 Feb; 60(3):388-98. PubMed ID: 18068261
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of surfactant and pH on dissolution properties of fenofibrate and glipizide--a technical note.
    Jamzad S; Fassihi R
    AAPS PharmSciTech; 2006 Apr; 7(2):E33. PubMed ID: 16796351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.